Consensus recommendations for the use of automated insulin delivery technologies in clinical practice

M Phillip, R Nimri, RM Bergenstal… - Endocrine …, 2023 - academic.oup.com
The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

Closed-loop insulin delivery systems: past, present, and future directions

S Templer - Frontiers in Endocrinology, 2022 - frontiersin.org
Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened
to the holy grail of diabetes management. The first iterations of glucose-responsive insulin …

[PDF][PDF] ISPAD clinical practice consensus guidelines 2018: diabetes technologies

JL Sherr, M Tauschmann, T Battelino, M de Bock… - Pediatr Diabetes, 2018 - bnsde.org
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system

C Rosselot, Y Li, P Wang, A Alvarsson… - Science Translational …, 2024 - science.org
Five hundred thirty-seven million people globally suffer from diabetes. Insulin-producing β
cells are reduced in number in most people with diabetes, but most individuals still have …

A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy

C Berget, LH Messer… - Diabetes spectrum: a …, 2019 - pmc.ncbi.nlm.nih.gov
A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present,
and Future of Intensive Therapy - PMC Skip to main content Here's how you know Official …

Cost, hassle, and on-body experience: barriers to diabetes device use in adolescents and potential intervention targets

LH Messer, ML Tanenbaum, PF Cook… - Diabetes technology …, 2020 - liebertpub.com
Background: Adolescents with diabetes have the highest A1cs of all age groups. Diabetes
devices (insulin pumps and continuous glucose monitors [CGM]) can improve glycemic …

Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy

J Fuchs, R Hovorka - Expert review of medical devices, 2020 - Taylor & Francis
Introduction Type 1 diabetes is a lifelong disease with high management burden. The
majority of people with type 1 diabetes fail to achieve glycemic targets. Algorithm-driven …

[HTML][HTML] Current diabetes technology: striving for the artificial pancreas

N Allen, A Gupta - Diagnostics, 2019 - mdpi.com
Diabetes technology has continually evolved over the years to improve quality of life and
ease of care for affected patients. Frequent blood glucose (BG) checks and multiple daily …

A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm

LH Messer, C Berget, GP Forlenza - Diabetes technology & …, 2019 - liebertpub.com
Advanced diabetes devices are the most sophisticated technologies available for self-
management of insulinrequiring diabetes. 1, 2 Advanced diabetes devices are insulin …

Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis

V Karageorgiou, TG Papaioannou, I Bellos… - Metabolism, 2019 - Elsevier
Objective Artificial pancreas is a technology that minimizes user input by bridging
continuous glucose monitoring and insulin pump treatment, and has proven safety in the …